Cardiovascular System Drugs – Summary
... Some drugs (i.e.: atenolol) have ‘cardio selectivity’ – they selectively bind to beta1-adrenoceptors located in the heart – having a predominant effect on the heart. ‘Cardio selectivity’ for atenolol is only for low doses, high dose regimes produces effects on heart and respiratory airways. Othe ...
... Some drugs (i.e.: atenolol) have ‘cardio selectivity’ – they selectively bind to beta1-adrenoceptors located in the heart – having a predominant effect on the heart. ‘Cardio selectivity’ for atenolol is only for low doses, high dose regimes produces effects on heart and respiratory airways. Othe ...
Addiction: brain mechanisms and their treatment implications
... physically dependent addicts and, because they do not provide any reinforcement, there is little incentive for addicts to stay on them. Naltrexone is useful in highly motivated individuals in whom relapse to opioid use could portend the end of their career (eg, doctors and pharmacists). This antagon ...
... physically dependent addicts and, because they do not provide any reinforcement, there is little incentive for addicts to stay on them. Naltrexone is useful in highly motivated individuals in whom relapse to opioid use could portend the end of their career (eg, doctors and pharmacists). This antagon ...
PIO Nas - Badan Pengawas Obat dan Makanan
... expectorations, shows effects as antagonizing the formation “in loco” of free radicals and ascontrasting the action of elastase enzyme. From pharmacological studies results that Erdosteine, as such, does not posses these properties but only after metabolization, into active metabolites which have th ...
... expectorations, shows effects as antagonizing the formation “in loco” of free radicals and ascontrasting the action of elastase enzyme. From pharmacological studies results that Erdosteine, as such, does not posses these properties but only after metabolization, into active metabolites which have th ...
Lindane: Organophasphate Chemical
... Environmental Protection Agency’s (EPA) National Priority List (NPL) sites (out of a total of 1,662) – Is a persistent organic pollutant ...
... Environmental Protection Agency’s (EPA) National Priority List (NPL) sites (out of a total of 1,662) – Is a persistent organic pollutant ...
1: Gastro-intestinal system - Gateshead Health NHS Foundation Trust
... Article date: May 2012 Summary ...
... Article date: May 2012 Summary ...
- Know Tech Phar | Select language
... Tanacetum by blocking of potassium channel would also inhibit the spasms of smooth muscles of arteries and hence, it is effective in inhibit migraine headaches. 4-Blending the German chamomile´s component in this capsule, and its important effective ingredient namely: Apigenin that acts as a ligand ...
... Tanacetum by blocking of potassium channel would also inhibit the spasms of smooth muscles of arteries and hence, it is effective in inhibit migraine headaches. 4-Blending the German chamomile´s component in this capsule, and its important effective ingredient namely: Apigenin that acts as a ligand ...
Migraphar Capsule, 240 mg.
... Tanacetum by blocking of potassium channel would also inhibit the spasms of smooth muscles of arteries and hence, it is effective in inhibit migraine headaches. 4-Blending the German chamomile´s component in this capsule, and its important effective ingredient namely: Apigenin that acts as a ligand ...
... Tanacetum by blocking of potassium channel would also inhibit the spasms of smooth muscles of arteries and hence, it is effective in inhibit migraine headaches. 4-Blending the German chamomile´s component in this capsule, and its important effective ingredient namely: Apigenin that acts as a ligand ...
EVALUATION OF MORINGA OLEIFERA ROOTS AND FLOWERS
... used as better topical drug delivery systems over present conventional systems available in market4. Clindamycin is a lincosamide antibiotic. It is usually used to treat infections with anaerobic bacteria, but can also be used to treat some protozoal diseases, such as malaria. It is a common topical ...
... used as better topical drug delivery systems over present conventional systems available in market4. Clindamycin is a lincosamide antibiotic. It is usually used to treat infections with anaerobic bacteria, but can also be used to treat some protozoal diseases, such as malaria. It is a common topical ...
Itraconazole
... drug or any ingredient in the formulation. Patients who have severe hepatic disease are not advised to take Itraconazole. It is not advisable to use the drug in patients taking rifampin, which appears to initially inhibit and then enhance the metabolism of Itraconazole. PRECAUTION Absorption is impa ...
... drug or any ingredient in the formulation. Patients who have severe hepatic disease are not advised to take Itraconazole. It is not advisable to use the drug in patients taking rifampin, which appears to initially inhibit and then enhance the metabolism of Itraconazole. PRECAUTION Absorption is impa ...
the cost of medicine - Doctors Without Borders
... allowed, help push prices down. But the license agreements exclude 38 developing and so-called “middle income countries,” or MICs, which is problematic because an estimated 75 percent of the world’s poorest people and over 70 percent of people with hepatitis C live in MICs, meaning many patients wil ...
... allowed, help push prices down. But the license agreements exclude 38 developing and so-called “middle income countries,” or MICs, which is problematic because an estimated 75 percent of the world’s poorest people and over 70 percent of people with hepatitis C live in MICs, meaning many patients wil ...
Antipsychotics Antimanics Antidepressants
... within a few hours of a single dose or at the most in the first week of therapy Akathisia (motor restlessness, feeling of discomfort, apparent agitation manifested as a compelling desire to move about, but without anxiety, is seen in some patients between 1–8 weeks of therapy:), and Tardive dyskines ...
... within a few hours of a single dose or at the most in the first week of therapy Akathisia (motor restlessness, feeling of discomfort, apparent agitation manifested as a compelling desire to move about, but without anxiety, is seen in some patients between 1–8 weeks of therapy:), and Tardive dyskines ...
2nd Quarter Conference Call - Emisphere Technologies, Inc.
... Safe Harbor Statement Regarding Forward-Looking Statements ...
... Safe Harbor Statement Regarding Forward-Looking Statements ...
Drug Repositioning Approaches for the Discovery of New ’s Disease REVIEW
... 1980s, “rational” target-based drug discovery served as a dominant trend in the pharmaceutical industry [19]. In target-based drug discovery, small molecule screening of compound libraries consisting of structurally diverse small molecules is conduced to find compounds that bind specifically to the ...
... 1980s, “rational” target-based drug discovery served as a dominant trend in the pharmaceutical industry [19]. In target-based drug discovery, small molecule screening of compound libraries consisting of structurally diverse small molecules is conduced to find compounds that bind specifically to the ...
Cholinoceptor blocking drugs
... • They are known as oxime agents and include Pralidoxime (PAM) & diacetylmonoxime • The oxime group has a high affinity for binding with Phosphorus atom and hydrolyze the phosphorylated enzyme. pralidoxime i.v.1-2 g for over 15-30 min. and for several days in severe poisoning. • This drug may cause ...
... • They are known as oxime agents and include Pralidoxime (PAM) & diacetylmonoxime • The oxime group has a high affinity for binding with Phosphorus atom and hydrolyze the phosphorylated enzyme. pralidoxime i.v.1-2 g for over 15-30 min. and for several days in severe poisoning. • This drug may cause ...
New Steps Aimed at Cutting Risks from Acetaminophen
... risk of acetaminophen-related liver injury from OTC products. In its Januar y 2011 announcement, FDA emphasized that combination products that contain 325 milligrams of acetaminophen (or less) per dosage unit are effective for treating pain. The new dosage limit will not affect other aspects of pres ...
... risk of acetaminophen-related liver injury from OTC products. In its Januar y 2011 announcement, FDA emphasized that combination products that contain 325 milligrams of acetaminophen (or less) per dosage unit are effective for treating pain. The new dosage limit will not affect other aspects of pres ...
1 The Neuromuscular Junction: Pharmacology
... Tubocurarine is a reversible competitive antagonist that vies with acetylcholine for binding to the α-subunits of ACh receptors, thus reducing the response to ACh released by motor nerve terminals. Binding of tubocurarine is reversible: that is, it can be out-competed by elevating the ACh concentrat ...
... Tubocurarine is a reversible competitive antagonist that vies with acetylcholine for binding to the α-subunits of ACh receptors, thus reducing the response to ACh released by motor nerve terminals. Binding of tubocurarine is reversible: that is, it can be out-competed by elevating the ACh concentrat ...
Phytochemistry 1
... Prolonged storage of anthracene bearing drugs may bring oxidation of anthranols and anthrones (contains keto group) to give the less active anthraquinones. Thus, the activity of drugs decreases by time. However, anthraquinone glycosides do not cause any griping action (like anthranol and anthone), t ...
... Prolonged storage of anthracene bearing drugs may bring oxidation of anthranols and anthrones (contains keto group) to give the less active anthraquinones. Thus, the activity of drugs decreases by time. However, anthraquinone glycosides do not cause any griping action (like anthranol and anthone), t ...
Modern Methods in Drug Discovery
... • the field of application or the mode of action is new • it shows a better effiacy than existing drugs • it is better tolerated or shows less adverse effects • it has a different administration [Darreichungsform] (Galenik) ...
... • the field of application or the mode of action is new • it shows a better effiacy than existing drugs • it is better tolerated or shows less adverse effects • it has a different administration [Darreichungsform] (Galenik) ...
Template Kwartaalbericht
... Other biguanides like phenformin and buphormin, have been withdrawn from the market in the 1970s in many countries because of the risk of lactic acidosis[4]. Lactic acidosis, associated with the use of metformin, however, is a rare event and may occur with an average incidence rate of 3 per 100,000 ...
... Other biguanides like phenformin and buphormin, have been withdrawn from the market in the 1970s in many countries because of the risk of lactic acidosis[4]. Lactic acidosis, associated with the use of metformin, however, is a rare event and may occur with an average incidence rate of 3 per 100,000 ...